JPRN-UMIN000006615已完成未知
Phase I/II study of docetaxel/nedaplatin/5-FU for advanced esophageal cancer - Phase I/II study of DNF for advanced esophageal cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) other active cancers 2) patients who want to be pregnant or pregnant woman 3)severe pshychological disorder 4) prior or current history of steroidal treatments 5) HBsAG(+) 6) Severe DM 7) History of Severe complications 8) History of cardiac infarction 9)Acative infection 10)inappropriate cases for a clinical trials
研究者
相似试验
招募中
不适用
A Phase II trial of Nedaplatin, 5FU and Docetaxel for induction chemotherapy with Local advanced squamous cell carcinoma of the Head and Neckocal advanced squamous cell carcinoma of the Head and NeckJPRN-UMIN000022191Kindai nara hospital30
已完成
2 期
Phase II trial of 5FU/Docetaxel /Nedaplatin combination therapy for Recurrence or Metastatic Esophageal cancerEsophageal cancerJPRN-UMIN000017685Kinki university Faculty of Medicine25
进行中（未招募）
1 期
A Phase II Trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic carcinoma of the penis - Penile TPFocally advanced and metastatic carcinoma of the penisMedDRA version: 13.1Level: LLTClassification code 10034299Term: Penile cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-000707-28-GBThe Institute of Cancer Research29
已完成
2 期
Phase II study of docetaxel/cisplatin/5-fluorouracil combination chemotherapy for advanced esophageal canceresophageal cancerJPRN-UMIN000008400Jikei university school of medicine, department of oncology and hematology, department of gastroenterological surgery60
尚未招募
不适用
Phase I/II study of docetaxel/CDGP/5-FU for advanced or recurrent esophageal cancerEsophageal cancerJPRN-UMIN000014462Tokushima University28